MNKD Snapshot | |
---|---|
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California. | |
VALUATION DATA | |
Market Capitalization | $1,252,035,000 | Price to Sales | 1.00 |
Earnings per Share | $-0.0400 |
PE Ratio | None |
PRICE DATA | |
Most Recent Close | $4.5300 |
52 Week High | $6.29 |
52 Week Low | $- |
50-Day Moving Average | $6.19 |
200-Day Moving Average | $59.76 |
All data are from Alpha Vantage as of today. For more infomation on MNKD see Stock Dividend, Valuation, Price and Financial Data for Investors |